ArticleFrontiers in pharmacology2022

Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma.

Xun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.